Product Details
RITUXAN 100MG 10ML VL EA
Manufacturer: GENENTECH, INC
MFG#: 50242-0051-21
NDC: 50242-0051-21
PID: 639386
1/EA
$953.25
In StockAdditional Information
| Product Name | Rituxan 100 mg/10 mL Vial |
| Active Ingredient | Rituximab |
| Therapeutic Class | Monoclonal Antibody |
| Mechanism of Action | Binds to CD20 on B-lymphocytes, leading to cell depletion |
| Concentration | 100 mg/10 mL (10 mg/mL) |
| Dosage Form | Intravenous (IV) Infusion Solution |
| Preparation | Requires dilution before administration |
| Common Adverse Effects | Infusion reactions, fever, chills, nausea, fatigue, infections |
| Serious Adverse Effects | Progressive multifocal leukoencephalopathy (PML), severe infections, hepatitis B reactivation, cardiac events |
| Pre-medication Required | Antihistamines and antipyretics to reduce infusion reactions |
| Storage Conditions | 2°C to 8°C (36°F to 46°F), protect from light, do not freeze or shake |
| Indications | Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis, Microscopic Polyangiitis |
Description
Rituxan 100 mg/10 mL Vial is a monoclonal antibody used in the treatment of certain autoimmune diseases and cancers. It targets the CD20 antigen found on the surface of B-lymphocytes, leading to their depletion. Rituxan is primarily indicated for non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, and microscopic polyangiitis.
The formulation is supplied as a sterile, preservative-free solution in a single-use vial. It is administered as an intravenous infusion under medical supervision due to the risk of infusion-related reactions. Pre-medication with antipyretics and antihistamines is often required to minimize adverse effects. The infusion must be prepared and diluted in an appropriate IV solution before administration.
Common adverse reactions include infusion-related reactions, fever, chills, nausea, fatigue, and infections due to immunosuppression. Serious complications may involve severe infections, reactivation of hepatitis B virus, progressive multifocal leukoencephalopathy (PML), and cardiac events.
Frequently Asked Questions (FAQs)
The cost of RITUXAN 100MG 10ML VL EA is $$953.25
RITUXAN 100MG 10ML VL EA is manufactured by GENENTECH, INC.
You can purchase RITUXAN 100MG 10ML VL EA on our website at https://supplies.pipelinemedical.com/product/detail/rituxan-100mg-10ml-vl-ea-648344